Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Neuronal acetylcholine receptor; alpha3/beta4 | Starlite/ChEMBL | References |
Rattus norvegicus | Neuronal acetylcholine receptor; alpha3/beta2 | Starlite/ChEMBL | References |
Rattus norvegicus | Sigma opioid receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Neuronal acetylcholine receptor; alpha4/beta2 | Starlite/ChEMBL | References |
Rattus norvegicus | Neuronal acetylcholine receptor; alpha2/beta4 | Starlite/ChEMBL | References |
Rattus norvegicus | Neuronal acetylcholine receptor; alpha4/beta4 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0928 | 1 | 0.5 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.0928 | 1 | 0.5 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0445 | 0.3103 | 0.1994 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0445 | 0.3103 | 0.1994 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.0928 | 1 | 1 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0376 | 0.2123 | 1 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0445 | 0.3103 | 0.1994 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.0928 | 1 | 1 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0928 | 1 | 0.5 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.0928 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0445 | 0.3103 | 0.3103 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0928 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0928 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Agonist activity at alpha1betagammadelta nACHR in human TE671/RD cells by 86Rb+ efflux assay | ChEMBL. | 22148173 | |
Ki (binding) | Binding affinity to rat alpha7 nACHR at 10 uM | ChEMBL. | 22148173 | |
Ki (binding) | = 23.8 nM | Displacement of [3H]epibatidine from rat alpha4beta2 nACHR | ChEMBL. | 22148173 |
Ki (binding) | = 27.5 nM | Displacement of [3H]epibatidine from rat alpha4beta4 nACHR | ChEMBL. | 22148173 |
Ki (binding) | = 47.9 nM | Displacement of [3H]epibatidine from rat alpha2beta2 nACHR | ChEMBL. | 22148173 |
Ki (binding) | = 58 nM | Displacement of [3H]epibatidine from rat alpha2beta4 nACHR | ChEMBL. | 22148173 |
Ki (binding) | = 186 nM | Displacement of [3H]epibatidine from rat alpha3beta4 nACHR | ChEMBL. | 22148173 |
Ki (binding) | = 328 nM | Displacement of [3H]pentazocine from sigma 1 receptor in rat brain membrane after 2.5 hrs by microbeta scintillation counting analysis | ChEMBL. | 23641311 |
Ki (binding) | = 362 nM | Displacement of [3H]epibatidine from rat alpha3beta2 nACHR | ChEMBL. | 22148173 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.